Overview

4 Versus 6 Courses of Adjuvant Chemotherapy in LACC Patients Previously Treated With NACT Plus Radical Surgery

Status:
Completed
Trial end date:
2014-09-01
Target enrollment:
Participant gender:
Summary
The investigators primary outcome was to evaluate the effectiveness in term of Overall Survival (OS) and disease free interval (DFI) of two different platinum-based chemotherapic regimen (3 and 6 cycles) for treatment of Locally Advanced Cervical Cancer (LACC) (IB2-IIB) previously treated with Neoadjuvant Chemotherapy Plus Radical Surgery (NACT+RS). The secondary outcome was to evaluate and compare safety, in term of toxicity profile, of the two treatment options.
Phase:
N/A
Details
Lead Sponsor:
Campus Bio-Medico University
Treatments:
Albumin-Bound Paclitaxel
Cisplatin
Paclitaxel